RecruitingNCT05471232

Mental Health Crises in Youth With IDDs

Understanding Mental Health Crises in Youth With Intellectual and Developmental Disabilities

Sponsor

Rady Pediatric Genomics & Systems Medicine Institute

Enrollment

150 participants

Start Date

Mar 29, 2023

Study Type

OBSERVATIONAL

Conditions

Intellectual Disability

Summary

This study is an unmatched, case-control study of 150 youth (Ages 7-17) with a parent reported Intellectual Developmental Disability (IDD) who present to Rady Children's Hospital Emergency Department with a Mental Health Crisis (MHC). Rady Children's Institute for Genomic Medicine (RCIGM) will collect biological samples (such as blood) of these participants to study their genomes, medical and psychiatric profiles to better understand specific characteristics that may predispose them to MHC's. The 150 youth will be compared to historical, publicly available cohorts of youth with IDD's

Eligibility

Min Age: 7 YearsMax Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying EHR-Based Network Model and Genomic sequencing and molecular diagnostic results, if any. for people with intellectual disability. The study is currently recruiting participants at 1 location. People eligible for this study include aged 7 Years to 17 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

GENETICGenomic sequencing and molecular diagnostic results, if any.

Genomic sequencing results may be used for diagnosis and treatment of participants.

OTHEREHR-Based Network Model

EHR-based network will be created to predict psychiatric outcomes in youth with IDDs

Locations(1)

Rady Children's Hospital San Diego

San Diego, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05471232

Related Trials

Characterization of Nociception Phenotype in Individuals With Intellectual Disability

NCT054734291 location

Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities

NCT069971981 location